PATENT CLAIM ANALYSIS

Application Number: 15875010
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "134100"]

Abstract:
This invention relates to molecules, particularly polypeptides, more particularly fusion proteins that include a serpin polypeptide or an amino acid sequence that is derived from a serpin and second polypeptide comprising of at least one the following: an Fc polypeptide or an amino acid sequence that is derived from an Fc polypeptide; a cytokine targeting polypeptide or a sequence derived from a cytokine targeting polypeptide; a WAP domain containing polypeptide or a sequence derived from a WAP containing polypeptide; and an albumin polypeptide or an amino acid sequence that is derived from a serum albumin polypeptide. This invention also relates to methods of using such molecules in a variety of therapeutic and diagnostic indications, as well as methods of producing such molecules.

Claim (Index 59):
The isolated fusion protein of  claim 54 , wherein the human AAT polypeptide comprises of the amino acid sequence of SEQ ID NO: 32 operably linked to an immunoglobulin Fc polypeptide comprising the amino acid sequence of SEQ ID NO: 6.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 2.33929
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13536976', '14524832', '13536987', '14616351', '14649187']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8449267759905471
- 35 USC 102 Novelty (BERT): 0.6755371408042672
- Combined Prediction Score: 0.8279878124719192
- Mean Citation Score: 704.3090760000001
- Max Citation Score: 813.9759
- Similarity Product: 654.3620696655214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test